181 related articles for article (PubMed ID: 24946951)
1. Metadherin expression and lung relapse in patients with colorectal carcinoma.
Casimiro S; Fernandes A; Oliveira AG; Franco M; Pires R; Peres M; Matias M; Tato-Costa J; Guerra N; Ramos M; Cruz J; Costa L
Clin Exp Metastasis; 2014 Aug; 31(6):689-96. PubMed ID: 24946951
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of metadherin inhibits cell proliferation and migration in colorectal cancer.
Li JW; Huang CZ; Li JH; Yuan JH; Chen QH; Zhang WF; Xu ZS; Liu YP; Li Y; Zhan MX; Lu LG
Oncol Rep; 2018 Oct; 40(4):2215-2223. PubMed ID: 30015962
[TBL] [Abstract][Full Text] [Related]
3. Metadherin (MTDH) overexpression significantly correlates with advanced tumor grade and stages among colorectal cancer patients.
Sultan A; Sahar NE; Riaz SK; Qadir J; Waqar SH; Haq F; Khaliq T; Malik MFA
Mol Biol Rep; 2021 Dec; 48(12):7999-8007. PubMed ID: 34741710
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of metadherin/MTDH is associated with an aggressive phenotype and a poor prognosis in invasive breast cancer.
Tokunaga E; Nakashima Y; Yamashita N; Hisamatsu Y; Okada S; Akiyoshi S; Aishima S; Kitao H; Morita M; Maehara Y
Breast Cancer; 2014 May; 21(3):341-9. PubMed ID: 22903204
[TBL] [Abstract][Full Text] [Related]
5. Metadherin (AEG-1/MTDH/LYRIC) expression: Significance in malignancy and crucial role in colorectal cancer.
Abdel Ghafar MT; Soliman NA
Adv Clin Chem; 2022; 106():235-280. PubMed ID: 35152973
[TBL] [Abstract][Full Text] [Related]
6. Significance of dysregulated metadherin and microRNA-375 in head and neck cancer.
Hui AB; Bruce JP; Alajez NM; Shi W; Yue S; Perez-Ordonez B; Xu W; O'Sullivan B; Waldron J; Cummings B; Gullane P; Siu L; Liu FF
Clin Cancer Res; 2011 Dec; 17(24):7539-50. PubMed ID: 22031094
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of metadherin protein predicts worse disease-free and overall survival in laryngeal squamous cell carcinoma.
Liu Y; Su Z; Li G; Yu C; Ren S; Huang D; Fan S; Tian Y; Zhang X; Qiu Y
Int J Cancer; 2013 Aug; 133(3):671-9. PubMed ID: 23364922
[TBL] [Abstract][Full Text] [Related]
8. Effect of modification of MTDH gene expression on colorectal cancer aggressiveness.
El-Ashmawy NE; El-Zamarany EA; Khedr EG; Abo-Saif MA
Gene; 2019 May; 698():92-99. PubMed ID: 30836117
[TBL] [Abstract][Full Text] [Related]
9. Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patients.
Mizrak Kaya D; Dong X; Nogueras-González GM; Xu Y; Estrella JS; Harada K; Lopez A; Amlashi FG; Hofstetter WL; Maru DM; Nguyen QN; Lee JH; Weston B; Bhutani MS; Erasmus JJ; Thomas I; Rogers JE; Song S; Ajani JA
Med Oncol; 2017 Aug; 34(8):135. PubMed ID: 28685276
[TBL] [Abstract][Full Text] [Related]
10. Activation of EMT in colorectal cancer by MTDH/NF-κB p65 pathway.
El-Ashmawy NE; El-Zamarany EA; Khedr EG; Abo-Saif MA
Mol Cell Biochem; 2019 Jul; 457(1-2):83-91. PubMed ID: 30825051
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of MTDH predicts better prognosis of locally advanced HER-2 positive breast cancer patients receiving neoadjuvant chemotherapy plus trastuzumab.
Wang X; Cai L; Ye F; Li M; Ma L; Geng C; Song Z; Liu Y
Medicine (Baltimore); 2019 Sep; 98(36):e16937. PubMed ID: 31490377
[TBL] [Abstract][Full Text] [Related]
12. High expression of metadherin correlates with malignant pathological features and poor prognostic significance in papillary thyroid carcinoma.
Li WF; Wang G; Zhao ZB; Liu CA
Clin Endocrinol (Oxf); 2015 Oct; 83(4):572-80. PubMed ID: 25418110
[TBL] [Abstract][Full Text] [Related]
13. The multifaceted role of MTDH/AEG-1 in cancer progression.
Hu G; Wei Y; Kang Y
Clin Cancer Res; 2009 Sep; 15(18):5615-20. PubMed ID: 19723648
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Targeting of Metadherin Suppresses Colorectal and Lung Cancer Progression and Metastasis.
Shen M; Xie S; Rowicki M; Michel S; Wei Y; Hang X; Wan L; Lu X; Yuan M; Jin JF; Jaschinski F; Zhou T; Klar R; Kang Y
Cancer Res; 2021 Feb; 81(4):1014-1025. PubMed ID: 33239430
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of Metadherin-SND1 interaction in colon cancer.
Wang N; Du X; Zang L; Song N; Yang T; Dong R; Wu T; He X; Lu J
Mol Biol Rep; 2012 Dec; 39(12):10497-504. PubMed ID: 23065261
[TBL] [Abstract][Full Text] [Related]
16. Genetic ablation of metadherin inhibits autochthonous prostate cancer progression and metastasis.
Wan L; Hu G; Wei Y; Yuan M; Bronson RT; Yang Q; Siddiqui J; Pienta KJ; Kang Y
Cancer Res; 2014 Sep; 74(18):5336-47. PubMed ID: 25074613
[TBL] [Abstract][Full Text] [Related]
17. Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.
Mataki H; Seki N; Mizuno K; Nohata N; Kamikawaji K; Kumamoto T; Koshizuka K; Goto Y; Inoue H
Oncotarget; 2016 Nov; 7(44):72084-72098. PubMed ID: 27765924
[TBL] [Abstract][Full Text] [Related]
18. The RNA binding protein neuro-oncological ventral antigen 1 (NOVA1) regulates IL-6 mRNA stability to enhance JAK2-STAT3 signaling in CRC.
Hong YG; Xu GS; Yu GY; Zhou JD; Liu QZ; Ni JS; Yan HL; Zhang W; Hao LQ
Surg Oncol; 2019 Dec; 31():67-74. PubMed ID: 31541909
[TBL] [Abstract][Full Text] [Related]
19. A Preliminary Study on Metadherin as a Potential Marker for Progression of Diffuse Large B Cell Lymphoma.
Ge X; Sui X; Fang X; Jiang Y; Ding M; Liu X; Wang X
Genet Test Mol Biomarkers; 2018 Aug; 22(8):481-486. PubMed ID: 30117777
[TBL] [Abstract][Full Text] [Related]
20. Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.
Meng X; Zhu D; Yang S; Wang X; Xiong Z; Zhang Y; Brachova P; Leslie KK
J Biol Chem; 2012 Feb; 287(7):4485-91. PubMed ID: 22199357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
